Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation: A single center experience

Digestive Diseases and Sciences

Volumn 54, Issue 6, 2009, Pages 1347-1354

  Egawa, Hiroto ^a   Taira, Kaoru ^b   Teramukai, Satoshi ^a   Haga, Hironori ^a,b   Ueda, Yoshihide ^a,b   Yonezawa, Atsushi ^b   Masuda, Satohiro ^b   Tsuji, Hiroaki ^a   Ashihara, Eishi ^a   Takada, Yasutsugu ^b   Uemoto, Shinji ^a,b  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Cytomegalovirus; Living donor liver transplantation; Primary sclerosing cholangitis; Recurrence; Risk factor

Indexed keywords

ACICLOVIR; AZATHIOPRINE; GANCICLOVIR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; DRUG DOSE REDUCTION; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; MALE; PARENT; PRESCHOOL CHILD; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD;

ACYCLOVIR; ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; CHOLANGITIS, SCLEROSING; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GRAFT VS HOST DISEASE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 67349211013     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-0773-9     Document Type: Article

References (20)

1. AJ Demetris 2006 Distinguishing between recurrent primary sclerosing cholangitis and chronic rejection Liver Transplant 12 S68 S72
2. F Gordon 2006 Recurrent primary sclerosing cholangitis: clinical diagnosis and long-term management issues Liver Transplant 12 S73 S75
3. M Gautam R Cheruvattath V Balan 2006 Recurrence of autoimmune liver disease after liver transplantation: a systemic review Liver Transplant 12 1813 1824
4. IW Graziadei RH Wiesner PJ Marotta MK Porayko E Hay MR Charton 1999 Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis Hepatology 30 1121 1127 (Pubitemid 29510847)
5. H Haga A Miyagawa-Hayashino K Taira D Morioka H Egawa Y Takada T Manabe S Uemoto 2007 Histological recurrence of autoimmune liver diseases after living-donor liver transplantation Hepatol Res 37 Suppl 3 S463 S469 (Pubitemid 47576917)
6. K Tanaka S Uemoto Y Tokunaga Y Sakai M Zaima Y Yamaoka 1993 Surgical techniques and innovation in living related liver transplantation Ann Surg 217 82 91 (Pubitemid 23033223)
7. M Kasahara H Egawa Y Takada F Oike S Sakamoto T Kiuchi 2006 Biliary reconstruction in right lobe living-donor liver transplantation: comparison of different techniques in 321 recipients Ann Surg 243 559 566
8. Y Inomata T Nakamura S Uemoto K Tanaka G Wakabayashi M Shimazu 2001 Domino split-liver transplantation from a living donor: case reports of in situ and ex situ splitting Liver Transplant 7 150 153 (Pubitemid 32166523)
9. + alloreactive responses toward early graft acceptance immediately after liver transplantation in humans Liver Transplant 13 1262 1271 (Pubitemid 47457053)
10. Banff Working Group AJ Demetris O Adeyi CO Bellamy A Clouston F Charlotte A Czaja 2006 Liver biopsy interpretation for causes of late liver allograft dysfunction Hepatology 44 489 501 (Pubitemid 44214890)
11. M Hashimoto T Kinoshita M Yamasaki A Murayama S Asai M Yamasaki 1994 Gene frequencies and haplotypic associations within the HLA region in 916 unrelated Japanese individuals Tissue Antigens 44 166 173 (Pubitemid 24298084)
12. L Halme K Hockerstedt I Lautenschlager 2003 Cytomegalovirus infection and development of biliary complications after liver transplantation Transplantation 75 1853 1858 (Pubitemid 36734642)
13. H Egawa Y Inomata S Uemoto K Asonuma T Kiuchi S Fujita 2001 Biliary anastomotic complications in 400 living related liver transplantations World J Surg 25 1300 1307 (Pubitemid 32952579)
14. Levitsky J, Singh N, Wagener MM, Stosor V, Abecassis M, Ison MG. A survey of CMV prevention strategies after liver transplantation. Am J Transplant. 2007;Oct 31 [Epub ahead of print].
15. E Cholongitas V Shusang GV Papatheodoridis L Marelli P Manousou N Rolando 2008 Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation Liver Transplant 14 138 143
16. J Alexander JD Lord MM Yeh C Cuevas R Bakthavatsalam KV Kowdley 2008 Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation Liver Transplant 14 245 251
17. S Tamura Y Sugawara J Kaneko Y Matsui J Togashi M Makuuchi 2007 Recurrence of primary sclerosing cholangitis after living donor liver transplantation Liver Int 27 86 94 (Pubitemid 46139432)
18. H Egawa Y Inomata S Uemoto K Asonuma T Kiuchi S Fujita 2001 Biliary anastomotic complications in 400 living related liver transplantation World J Surg 25 1300 1307 (Pubitemid 32952579)
19. D Debray D Pariente E Urvoas M Hadchouel O Bernard 1994 Sclerosing cholangitis in children J Pediatr 124 49 56 (Pubitemid 24027286)
20. JA Goss CR Shackleton DG Farmer WS Arnaout P Seu JS Markowitz 1997 Orthtotopic liver transplantation for primary sclerosing cholangitis a 12-year single center experience Ann Surg 225 472 483 (Pubitemid 28079096)